has received final approval from the to offer a new Ph.D. in Pharmaceutical Sciences degree program, officially adding the degree to the institution鈥檚 academic offerings.
The approval makes the program the first Ph.D. in Pharmaceutical Sciences degree of its kind in the Dallas-Fort Worth Metroplex.
The milestone marks the completion of the program鈥檚 regulatory and accreditation process, following prior approvals from the 天美mv天美 Board of Regents and the Texas Higher Education Coordinating Board.
With accreditation now finalized, UNT Health may officially admit students into the
program and move forward with recruitment and student-facing communications reflecting
the program鈥檚 fully approved status.
Housed within UNT Health鈥檚 , the doctoral program is designed to prepare scientists and researchers to advance drug discovery, development and translational research.
鈥淔ull approval allows us to officially admit students into a program designed to meet the evolving needs of the profession,鈥� said Evan Robinson, dean of the College of Pharmacy and Health Professions. 鈥淭his approval reflects years of intentional planning and collaboration, and it positions us to educate and support the next generation of pharmaceutical scientists at the highest level.鈥�
The program was developed in response to growing workforce demand within pharmaceutical
sciences and related research fields. It expands UNT Health鈥檚 graduate education and
research portfolio while building on the institution鈥檚 strengths in interdisciplinary
collaboration and health innovation.
鈥淭his is an exciting achievement for UNT Health and the College of Pharmacy and Health Professions, reflecting a collaborative effort to build a program focused on workforce development in pharmaceutical sciences,鈥� said Rebecca Cunningham, Ph.D., senior associate dean for research and program director. 鈥淲ith full accreditation in place, we are ready to advance research, foster innovation and train scientists to address complex challenges in the field.鈥�
Students in the program will complete a minimum of 60 semester credit hours and conduct dissertation research in one of four concentrations: medicinal chemistry, pharmaceutics, pharmacology and toxicology, or applied outcomes research.
Potential career paths for graduates include biotechnology, clinical pharmacology, drug design and development, formulation development, pharmacogenomics, regulatory sciences and pharmaceutical outcomes research.
The application deadline is July 1 for students who wish to begin classes this fall. Applicants must hold either a master鈥檚 degree or a Doctor of Pharmacy degree. More information is available at .
From Newsroom - by Nicole Luna